A DAILY pill that doubles survival time for lung cancer patients will be made routinely available on the NHS. Osimertinib, also known as Tagrisso and made by AstraZeneca, helps prevent cancer from ...
Whether working on active investigation sites or returning to a surviving structure, the American Lung Association highly recommends wearing a fresh and well-fitting N-95 or N-100 mask, which is a ...